Objective. To compare the effect of a conventional to an intensive blood pressure monitoring regimen on blood pressure in hypertensive patients in the general practice setting. Design. Randomized controlled parallel group trial with 12-month follow-up. Setting. One hundred and ten general practices in all regions of Denmark. Participants. One thousand forty-eight patients with essential hypertension. Intervention. Conventional blood pressure monitoring ('usual group') continued usual ad hoc blood pressure monitoring by office blood pressure measurements, while intensive blood pressure monitoring ('intensive group') supplemented this with frequent home blood pressure monitoring and 24-hour ambulatory blood pressure monitoring. Primary outcome measures. Mean day-and night-time systolic and diastolic 24-hour ambulatory blood pressure. Secondary outcome measures. Change in systolic and diastolic office blood pressure and change in cardiovascular risk profile. Results. Of the patients, 515 (49%) were allocated to the usual group, and 533 (51%) to the intensive group. The reductions in day-and night-time 24-hour ambulatory blood pressure were similar (usual group: 4.6 ± 13.5/2.8 ± 82 mmHg; intensive group: 5.6 ± 13.0/3.5 ± 8.2 mmHg; P = 0.27/P = 0.20). Cardiovascular risk scores were reduced in both groups at follow-up, but more so in the intensive than in the usual group (P = 0.02).
Introduction
Hypertensive patients with persistent sub-optimal blood control pressure remain a common challenge in general practice (1, 2) . To improve this, general practitioners (GPs) may replace or supplement office blood pressure with home blood pressure monitoring or 24-hour ambulatory blood pressure monitoring. Both home and 24-hour ambulatory blood pressure monitoring have the advantage of identifying white coat effect, white coat hypertension, and masked hypertension (3) . Moreover, 24-hour ambulatory blood pressure monitoring provides night-time values and information about blood pressure variability (3) .
A previous randomized controlled multi-centre trial encompassing both general practice and hospital outpatient clinics found that 24-hour ambulatory blood pressure monitoring led to better blood pressure control than conventional office blood pressure measurements (4) , and a later study found that adjusting anti-hypertensive treatment according to 24-hour ambulatory blood pressure monitoring was superior to office blood pressure measurements for reducing blood pressure (5) .
In the present Blood Pressure Reduction in Danish General Practice (BRIDGE) trial, we compared a conventional to an intensive blood pressure monitoring regimen in a randomized, controlled fashion in the general practice setting. While conventional blood pressure monitoring was a continuance of usual doctor-patient interaction in hypertension management with usual ad hoc office blood pressure measurements, intensive monitoring entailed frequent blood pressure assessments by office blood pressure measurements, home blood pressure measurements, and 24-hour ambulatory blood pressure monitoring, as well as enhanced patient information.
We hypothesized that intensive blood pressure monitoring would lead to better blood pressure control than conventional blood pressure monitoring. The primary endpoints for assessing blood pressure control were change in mean day-and night-time systolic and diastolic 24-hour ambulatory blood pressure. Secondary endpoints were change in systolic and diastolic office blood pressure and change in cardiovascular risk profile.
Methods

Design
The study was designed as a randomized controlled parallel group trial with 12-month follow-up (Fig. 1) . A total of 110 GPs in 110 separate practices were recruited representing all five regions in Denmark. The GPs were randomized by computer to perform either conventional or intensive blood pressure monitoring. Henceforth, patients treated according to the former are referred to as the 'usual group', while patients treated according to the latter are referred to as the 'intensive group'. A randomization within each region was performed to ensure an equal distribution of blood pressure monitoring practices. Before randomization, all participating physicians were updated on blood pressure treatment and thresholds for office, ambulatory and home blood pressure according to the Danish Society of Hypertension guidelines (6) . Normal blood pressure was defined as less than 140/90 mmHg for office blood pressure, and less than 135/85 mmHg for home and 24-hour ambulatory blood pressure.
Each GP recruited 10-12 patients, yielding a total of 1048 participants diagnosed with essential hypertension, defined as at least one office blood pressure above 140/90 mmHg, who were either newly diagnosed (n = 87) or received active anti-hypertensive therapy (n = 961). Patients were recruited consecutively. Exclusion criteria were age <18 years and pregnancy.
At baseline and follow-up, patients were evaluated by office and 24-hour ambulatory blood pressure measurements, and a cardiovascular risk score (Fig. 1) . Figure 1 . Study design. Hypertensive patients were allocated to the usual group or the intensive group in a randomized fashion. In the usual group, the individual GP decided the number of visits and the extent of blood pressure monitoring by office blood pressure measurement (OBPM) over the 12-month study period. At baseline and 12-month follow-up, 24-hour ambulatory blood pressure measurements (ABPM) were performed for the purpose of deriving primary and secondary endpoints, and the former of these was blinded to the GP. In the intensive group, ad hoc monitoring by office blood pressure measurements was supplemented by at least eight visits scheduled over the 12-month study period, using both home blood pressure measurement (HBPM) and ABPM for blood pressure monitoring; none of these measurements were blinded to the GP.
Usual group
The baseline 24-hour ambulatory blood pressure measurement was blinded to the GPs who continued usual ad hoc blood pressure monitoring by office blood pressure measurements (Fig. 1) . The frequency of visits and the extent of blood pressure monitoring by office blood pressure measurements was decided by the individual GP. According to GP routine practice, office blood pressure measurements registered in the clinical record form.
Intensive group
Blood pressure by office blood pressure measurements was supplemented 24-hour ambulatory and home blood pressure measurements. The baseline 24-hour ambulatory blood pressure measurements, along with home blood pressure measurements scheduled at month 1, 2, 4, 8 and 10, and supplementary 24-hour ambulatory blood pressure measurements after 6 months ( Fig. 1) were available to the GP, and registered in the clinical record form.
Patients received written information about hypertension including importance of blood pressure monitoring, life style interventions to reduce blood pressure and pharmacological management.
Blood pressure measurements
Office blood pressure was measured sitting after 5 minutes of rest and given as mean of the last 2 out of 3 measurements.
Twenty four-hour ambulatory blood pressure (Spacelabs 90207 or 90217, Spacelabs, Inc., Redmond, Washington) included measurement every 15 minutes during daytime and every 30 minutes during night-time. Daytime was defined as 07:00 a.m. to 10:59 p.m. Twenty four-hour ambulatory blood pressure monitoring was performed on days with routine patient activities. The average number of accepted measurements through 24 hours was 62 ± 13, and all recordings contained at least 40 usable measurements, including eight or more measurements at night.
Home blood pressure monitoring was performed using Microlife BP3AC1 (Microlife AG, Switzerland) and patients were carefully instructed by the GP both orally and in writing. Home blood pressure monitoring was done in the sitting position after 5 minutes of rest on 3 consecutive days. Each day, six measurements were performed with three before breakfast and three before dinner. Home blood pressure monitoring was evaluated by the average of the last 2 days.
All blood pressure measurements were performed with the appropriate cuff and measured in the arm with the highest office blood pressure or in the non-dominant arm in case of no difference.
Non-pharmacological and pharmacological treatment
Use of anti-hypertensive medication specified as drug class and dosage and non-pharmacological intervention was registered at each visit. In both the usual and intensive group, the choice of anti-hypertensive medication and the use of non-pharmacological intervention were entirely decided by the individual GP. Exercise, diet counselling, alcohol reduction and tobacco cessation were registered as nonpharmacological treatment.
Cardiovascular risk score
A cardiovascular risk score was calculated for each patient at baseline and at follow-up (6,7). The score (low, moderate, high and very high risk) is based on blood pressure, risk factors, target organ damage, and associated diseases (Supplementary Table S1 ).
Statistics
A power calculation showed that inclusion of 800 patients (400 in each group) would permit the detection of a 3.5 mmHg difference with a power of 90% at a 5% significance level, assuming a standard deviation of 15 mmHg. Patients in the intensive group with missing values during the last 6 to 12 months of the study were analysed by the principle 'last value carried forward'. Sensitivity analysis was performed around the assumptions for missing values.
Linear mixed effect models were applied to investigate differences in blood pressure reduction between groups. The GPs were included as a random effect in order to effectively model possible heterogeneity. The 24-hour ambulatory blood pressure at follow-up was the response variable was of the primary endpoint.
Reduction in 24-hour ambulatory blood pressure monitoring was included as a fixed effect covariate to adjust for possible differences in patient baseline values. Adjustments were made for the following risk factors at baseline: smoking, alcohol reduction, exercise, advice about diet, diabetic status, gender, and the continuous variables body mass index, and age.
Changes over time between groups with respect to the distribution of the risk factors smoking, alcohol reduction, exercise, and diet counselling, were compared using logistic regression models for each risk factor separately. In all models, we adjusted for age, gender, and diabetes.
Differences between two groups were assessed by Student's t-test for continuous parametric data, and by χ 2 test for categorical data.
Two-tailed P < 0.05 was considered statistically significant. R version 2.2.0 was used for all statistical analyses. The data were obtained at the first consultation. Age, weight and body mass index are given as mean ± SD. The remaining values are given as number of patients and percentage of patients within the group (usual or intensive group) in brackets. In the usual group, blood pressure was monitored ad hoc by office blood pressure measurements over the 12-month study period at the discretion of the individual GP. In the intensive group, ad hoc office blood pressure monitoring was supplemented by at least eight visits were scheduled during the 12-month study period, where blood pressure was evaluated by a combination of home blood pressure and 24-hour ambulatory blood pressure measurements.
Results
Of 1280 eligible patients, 1048 were included in the study. Of these, 515 (49%) were allocated to the usual group, and 533 (51%) to the intensive group. Patient characteristics are summarized in Table 1. A total of 143 patients dropped out during the study, 71 in the usual group and 72 in the intensive group. Drop out causes were death (7), withdrawal of consent (63), the GP ceased as investigator (40), and other reasons (33). There were no differences in dropouts between the two groups. Follow-up was completed by 86% (Fig. 2) .
Twenty four-hour ambulatory blood pressure monitoring
Apart from slightly higher diastolic daytime blood pressure in the intensive group, there were no differences in day-and night-time 24-hour ambulatory blood pressures between groups at baseline and at follow-up; the reductions in day-and night-time blood pressure in the two groups were thus similar (P = 0.27/P = 0.20; Table 2 ).
Office blood pressure
At baseline, systolic and diastolic office blood pressure was lower in the usual compared to the intensive group (Table 2) . At follow-up, office blood pressure was similar between groups, as it had decreased by 8.4 ± 17.3/3.4 ± 10.7 mmHg in the usual group, and by 13.0 ± 18.5/6.3 ± 11.4 mmHg in the intensive group after adjustment for baseline blood pressure and risk factors, and the office blood pressure reduction was accordingly more pronounced in the intensive group (P < 0.001, Table 2 ).
Visits and treatment
Patients in the intensive group had a higher number of visits to the GP than the usual group (total number of visits: 3202 versus 1540, P < 0.001).
Forty-four (9.9%) patients in the usual group and 43 (9.3%) in the intensive group did not receive anti-hypertensive medication at baseline. At follow-up, the values had decreased in both groups, to 24 (5.4%) and 26 (5.7%), respectively. Patients in the usual group received an average of 1.7 anti-hypertensive drugs at baseline, while patients in the intensive group received 1.6. At follow-up, the numbers of anti-hypertensive drugs were 1.8 and 1.9 for the usual and intensive group, respectively. Antihypertensive drug classes, use of lipid lowering agents and acetylic salicylic acid did not differ between groups (data not shown). Changes in doses of anti-hypertensive drugs were more frequent in the Intensive than in the usual group (P = 0.008), predominantly due to an increase in dose (data not shown).
Exercise and diet counselling were the most frequently prescribed non-pharmacological treatment. Exercise was prescribed at baseline to 70% and 60% and at follow-up to 63% and 50% in the Figure 2 . Study profile. In the usual group, blood pressure was monitored ad hoc by office blood pressure measurements over the 12-month study period at the discretion of the individual GP. In the intensive group, ad hoc office blood pressure monitoring was supplemented by at least eight visits were scheduled during the 12-month study period, where blood pressure was evaluated by a combination of home blood pressure and 24-hour ambulatory blood pressure measurements.
usual and intensive group, respectively (baseline versus follow-up, P < 0.001 and P < 0.001, respectively). Diet counselling was more persistently maintained in the Intensive compared to the usual group with 55%/44% and 52%/45%. No differences were observed concerning prescription of alcohol reduction and tobacco cessation at baseline.
Cardiovascular risk scores
The cardiovascular risk scores at baseline and follow-up are listed in Table 3 . A predominance of patients at baseline was classified as having a very high risk. There was no difference in cardiovascular risk score between groups at baseline. The cardiovascular risk score was improved in both groups at follow-up due to changes in the modifiable risk factors (smoking, dyslipidaemia, and abdominal obesity), but more patients moved from very high to lower risk groups in the Intensive than in the usual group (Table 3) .
Discussion
In contrast to our working hypothesis, there was no effect of intensive blood pressure monitoring on our primary endpoint, since the reduction in 24-hour ambulatory blood pressure monitoring at 12-month follow-up was similar in the usual and intensive group. We did, however, find a larger effect of intensive blood pressure monitoring on office blood pressure and the cardiovascular risk score, both of which were secondary endpoints.
The finding that 24-hour ambulatory blood pressure monitoring decreased similarly in the usual and intensive agrees with a recent general practice-based study on 220 hypertensive patients in Finland (8) , in which conventional ad hoc blood pressure monitoring with office blood pressure was found to reduce blood pressure similarly to a comprehensive intervention with extensive staff and patient education and frequent home blood pressure monitoring over a 12-month period. The blood pressure target for office blood pressure was 140/85 and 135/83 mmHg for home blood pressure, which is similar to the present study.
Our findings do, however differ from two previous studies that have compared office blood pressure to out-of-office measurements (9, 10) . In contrast to the present study, where the blood pressure Values are given in mean ± SD. In the usual group, blood pressure was monitored ad hoc by office blood pressure measurements over the 12-month study at the discretion of the individual GP. In the intensive group, ad hoc office blood pressure monitoring was supplemented by at least eight visits were scheduled during the 12-month study period, where blood pressure was evaluated by a combination of home blood pressure and 24-hour ambulatory blood pressure measurements. ABPM, 24-hour ambulatory blood pressure measurement; OBPM, office blood pressure measurement. Table S1 ). Data are presented percentage of patients within the group (usual or intensive group) with the given cardiovascular risk score (low, moderate, high or very high risk). In the usual group, blood pressure was monitored ad hoc by office blood pressure measurements over the 12-month study period at the discretion of the individual GP. In the intensive group, ad hoc office blood pressure monitoring was supplemented by at least eight visits were scheduled during the 12-month study period, where blood pressure was evaluated by a combination of home blood pressure and 24-hour ambulatory blood pressure measurements. ABPM, 24-hour ambulatory blood pressure measurement; OBPM, office blood pressure measurement. a 5.1 (2.2-8.1)% greater reduction from baseline than in usual group, P < 0.001. target differed depending on the modality for measuring blood pressure (office blood pressure: 140/90 mmHg; home and 24-hour ambulatory blood pressure: 135/85 mmHg), one of these studies adjusted the anti-hypertensive therapy according to similar diastolic blood pressure thresholds for both home and office blood pressure (diastolic blood pressure above > 89 mmHg: dose increase; 80-89 mmHg: maintain dose; <80 mmHg: reduce dose) (9), while a blood pressure <140/90 mmHg was targeted for both home blood and office blood pressure in the other study (10) . The patients monitored by home blood pressure in these studies may thus have undergone less intensive anti-hypertensive therapy than those monitored by 24-hour ambulatory blood pressure. In accordance with this notion, a controlled randomized trial comparing 24-hour ambulatory blood pressure to office blood pressure, and in which the treatment targets were adjusted to 140/90 mmHg for office blood pressure and 130/80 mmHg for 24-hour ambulatory blood pressure, found a greater blood pressure reduction when the latter was used (11) . The lower blood pressure target for 24-hour ambulatory blood pressure than in the present study may conceivably have led to more intensive anti-hypertensive therapy, and thus explain the discrepancy between studies.
The larger office blood pressure reduction observed in the Intensive compared to the usual group does not likely reflect that the former was subjected to a superior blood pressure monitoring strategy. Hence, the difference is largely caused by higher office blood pressure in the intensive group at baseline, a difference that evens out at follow-up. The finding that a similar change is not evident for 24-hour ambulatory blood pressure, suggests that a more prominent white coat effect was present in the intensive group at the onset of the trial. The present findings thus stress the importance of 24-hour ambulatory blood pressure monitoring in the management of hypertension in general practice, which is supported by a meta-analysis which concluded that 24-hour ambulatory blood pressure monitoring is superior to office blood pressure for predicting cardiovascular events (12) .
The cardiovascular risk score showed a greater reduction in the Intensive than in the usual group, due to changes in the modifiable risk factors smoking, dyslipidaemia, and abdominal obesity. Accordingly, our findings show that diet and exercise counselling were prescribed more frequently, and notably that diet counselling was maintained more persistently in the intensive group. The greater reduction in cardiovascular risk in the intensive group thus likely reflect derived beneficial effects of the more frequent patient-doctor contacts combined with enhanced patient education.
The main strengths of this study, apart from the controlled, randomized design with well-defined endpoints, are that it covered all regions of Denmark, and that a high completion rate of 86%, and that it included a broad spectrum of hypertensive patients in the general practice setting. The latter also comprises a major limitation, since patients were not stratified according to their a priori cardiovascular risk, which renders the patient population somewhat heterogeneous. Based on our data, it thus cannot be ruled out, that we would have observed differences on the primary endpoint or more of the secondary endpoints had the study focused exclusively on specific subgroups within the study.
In conclusion, the findings of the present BRIDGE trial indicate that although more an intensive blood pressure monitoring strategy may lead to higher doses of anti-hypertensive drugs, it does not necessarily cause a greater reduction in blood pressure than conventional ad hoc monitoring. However, a beneficial side effect of the more frequent doctor-patient contacts associated with a more intensive monitoring strategy may a reduction of other modifiable cardiovascular risk factors.
Supplementary Material
Supplementary data are available at Family Practice online.
